Herceptin (Trastuzumab): Side Effects, How it Works, and More
网页Herceptin (trastuzumab) can be an effective treatment both before and after surgery for people with HER2-positive breast cancer. Learn more.
Herceptin: Uses, Dosage & Side Effects - Drugs.com
网页2024年4月24日 · What is Herceptin? Herceptin is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Herceptin is used to treat certain types of breast cancer or stomach cancer. Other cancer medicines are sometimes used in combination with Herceptin.
HER2+ Breast & Stomach Cancer Treatment Option | Herceptin® …
网页Find information about Herceptin® (trastuzumab), a treatment for HER2+ early and metastatic breast cancer and stomach cancer/GEJ. See full safety & Boxed Warnings for more information.
What is Herceptin? Is Herceptin a chemo drug? How does it …
网页2023年10月9日 · Herceptin is a type of targeted therapy anticancer drug called a monoclonal antibody. Herceptin is used to treat cancers that are HER2 positive and is indicated for adjuvant breast cancer, metastatic breast cancer and metastatic gastric cancer.
What to Know About Herceptin for HER2 - WebMD
网页2024年4月15日 · Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and more.
Trastuzumab (Herceptin) - Breast Cancer Now
网页Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.
Genentech: Herceptin® (trastuzumab) - Information for Patients
网页Herceptin HYLECTA: What it treats Adjuvant Breast Cancer. HERCEPTIN HYLECTA (trastuzumab and hyaluronidase-oysk) is approved for the treatment of adults with early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2-positive and has not spread into the …
Trastuzumab (Intravenous Route) - Mayo Clinic
网页Trastuzumab injection is used to treat HER2-overexpressing new or metastatic (cancer that has spread) breast cancer. It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel).
Trastuzumab - NCI - National Cancer Institute
网页This binding blocks the ability of HER2-positive cancer cells to send chemical signals that tell them to grow. It also stimulates the immune system to kill cells that have a lot of HER2. Trastuzumab is a type of targeted therapy drug called a monoclonal antibody. US Brand Name (s) Herceptin. Hercessi.
Trastuzumab Uses, Side Effects & Warnings - Drugs.com
网页2024年3月26日 · If you are receiving Perjeta for treatment of HER2+ early breast cancer, you may continue treatments with Herceptin every 3 weeks for one year (18 cycles total).
- 某些结果已被删除一些您可能无法访问的结果已被隐去。显示无法访问的结果
跳至内容